Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice
暂无分享,去创建一个
D. Allan Butterfield | D. Butterfield | H. Poon | W. Pierce | J. Klein | V. Calabrese | M. Perluigi | W. Maragos | Vittorio Calabrese | C. Cini | Marzia Perluigi | Jon B. Klein | William M. Pierce | Carlo De Marco | H. Fai Poon | William Maragos | Chiara Cini | Carlo De Marco | D. A. Butterfield | William M. Pierce | Jon B. Klein | D. Butterfield
[1] Sarah J. Tabrizi,et al. Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity , 2000 .
[2] James R. Burke,et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.
[3] A. Panov,et al. Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. , 2004, Archives of biochemistry and biophysics.
[4] T. Hornemann,et al. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology , 1998, BioFactors.
[5] A. Morton,et al. Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation , 1999, The Journal of Neuroscience.
[6] S. Hersch,et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice , 2003, Journal of neurochemistry.
[7] E. Stadtman,et al. Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.
[8] Geoffrey Burnstock,et al. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice , 2004, Nature Medicine.
[9] M. Egan,et al. Creatine kinase and enolase: intracellular enzymes serving as markers of central nervous system damage in neuropsychiatric disorders. , 1992, Psychiatry.
[10] He Li,et al. Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease , 2003, The Journal of Neuroscience.
[11] K. Hoffmann‐Sommergruber,et al. Hev b 9, an enolase and a new cross-reactive allergen from hevea latex and molds. Purification, characterization, cloning and expression. , 2000, European journal of biochemistry.
[12] G. Donelli,et al. Cytoskeletal oxidative changes lead to alterations of specific cell surface receptors. , 1994, European Journal of Histochemistry.
[13] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[14] C A Ross,et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.
[15] H. Lehrach,et al. Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. , 2001, Human molecular genetics.
[16] B. Ames,et al. Oxidative Decay of DNA* , 1997, The Journal of Biological Chemistry.
[17] J. Gaillard,et al. Rapid inactivation of plant aconitase by hydrogen peroxide. , 1991, The Biochemical journal.
[18] W. Hemmer,et al. III-2 CREATINE KINASE IN NON-MUSCLE TISSUES AND CELLS , 1994 .
[19] P. Mecocci,et al. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex , 1999, Neuroscience Letters.
[20] M. Beal,et al. Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. , 1994, Biochemical Society transactions.
[21] M. Beal,et al. Oxidative Stress in Huntington's Disease , 1999, Brain pathology.
[22] D. Butterfield,et al. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain , 2004, Neuroscience.
[23] K. Fritz-Wolf,et al. Functional aspects of the X-ray structure of mitochondrial creatine kinase: A molecular physiology approach , 1998, Molecular and Cellular Biochemistry.
[24] G. Rondouin,et al. The role of free radicals in NMDA-dependent neurotoxicity. , 1994, Progress in brain research.
[25] D. Allan Butterfield,et al. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins , 2001, Mechanisms of Ageing and Development.
[26] W. Strittmatter,et al. In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. , 2003, Archives of biochemistry and biophysics.
[27] M. Mattson,et al. The Lipid Peroxidation Product, 4‐Hydroxy‐2‐trans‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins , 1997, Journal of neurochemistry.
[28] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[29] F. Gros,et al. Coexpression of alpha and gamma enolase genes in neurons of adult rat brain , 1994, Journal of neuroscience research.
[30] M. Beal. Oxidatively modified proteins in aging and disease. , 2002, Free radical biology & medicine.
[31] H. Beinert,et al. Mössbauer studies of beef heart aconitase: evidence for facile interconversions of iron-sulfur clusters. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Beal,et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.
[33] I. Alafuzoff,et al. Proteomic analysis of protein oxidation in Alzheimer's disease brain , 2002, Electrophoresis.
[34] W. Hemmer,et al. Creatine kinase in non-muscle tissues and cells , 1994, Molecular and Cellular Biochemistry.
[35] D. Butterfield,et al. Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease. , 2001, Current medicinal chemistry.
[36] T. Wallimann,et al. Oligomeric state and membrane binding behaviour of creatine kinase isoenzymes: Implications for cellular function and mitochondrial structure , 1998, Molecular and Cellular Biochemistry.
[37] D. Butterfield,et al. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.
[38] M. Wyss,et al. Octamer-dimer transitions of mitochondrial creatine kinase in heart disease. , 1999, Journal of molecular and cellular cardiology.
[39] Visith Thongboonkerd,et al. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. , 2002, Kidney international.
[40] M. Hayden,et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.
[41] G. Reynolds,et al. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases , 1985, Journal of the Neurological Sciences.
[42] M. MacDonald,et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.
[43] B. Kalyanaraman,et al. Rapid and irreversible inhibition of creatine kinase by peroxynitrite , 1998, FEBS letters.
[44] Edward L. Schneider,et al. Handbook of the Biology of Aging , 1990 .
[45] M. C. Whitehead,et al. Development of neuron-specific enolase immunoreactivity in avian nervous tissue in vivo and in vitro. , 1982, Brain research.
[46] D. Butterfield,et al. The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42 , 2001, Journal of neurochemistry.
[47] Isidro Ferrer,et al. Neuronal Induction of the Immunoproteasome in Huntington's Disease , 2003, The Journal of Neuroscience.
[48] P. R. Gardner,et al. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Butterfield,et al. Proteomics for the identification of specifically oxidized proteins in brain: Technology and application to the study of neurodegenerative disorders , 2003, Amino Acids.
[50] Alessandro Filla,et al. DNA damage induced by polyglutamine-expanded proteins. , 2003, Human molecular genetics.
[51] D. Allan Butterfield,et al. Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease , 2005, Neurobiology of Disease.
[52] Stephen B. Dunnett,et al. Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.
[53] D. Butterfield,et al. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .
[54] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.
[55] O. Andreassen,et al. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. , 2001, Neurobiology of disease.
[56] E. Stadtman,et al. Reactive oxygen-mediated protein oxidation in aging and disease. , 1997, Chemical research in toxicology.
[57] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[58] C. Ríos,et al. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease , 2000, Brain Research.
[59] S. Sorbi,et al. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain , 1983, Annals of neurology.
[60] D. Butterfield,et al. Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain , 2000, Journal of neurochemistry.
[61] G. Barbieri,et al. Structure of the human gene for α‐enolase , 1990 .
[62] D. Flint,et al. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. , 1993, The Journal of biological chemistry.
[63] S. Minotti,et al. Mutant Cu/Zn-Superoxide Dismutase Proteins Have Altered Solubility and Interact with Heat Shock/Stress Proteins in Models of Amyotrophic Lateral Sclerosis* , 2001, The Journal of Biological Chemistry.
[64] M. Rice,et al. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6‐hydroxydopamine , 2001, The European journal of neuroscience.
[65] M Crompton,et al. The mitochondrial permeability transition pore and its role in cell death. , 1999, The Biochemical journal.
[66] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. , 2002, Free radical biology & medicine.
[67] T. Wallimann,et al. Mitochondrial Creatine Kinase in Contact Sites: Interaction with Porin and Adenine Nucleotide Translocase, Role in Permeability Transition and Sensitivity to Oxidative Damage , 2001, Neurosignals.
[68] M. Beal,et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[69] M. Beal,et al. Experimental therapeutics in transgenic mouse models of Huntington's disease , 2004, Nature Reviews Neuroscience.
[70] W. Markesbery,et al. Protein Oxidation in Aging Brain a , 1992, Annals of the New York Academy of Sciences.
[71] D. Butterfield,et al. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration , 2003, Journal of neurochemistry.
[72] S. Augood,et al. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellularin situ hybridization study , 1996, Neuroscience.
[73] O. Andreassen,et al. Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease , 2001, Neurobiology of Disease.
[74] S. Tabrizi,et al. Biochemical abnormalities and excitotoxicity in Huntington's disease brain , 1999, Annals of neurology.
[75] O. Andreassen,et al. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease , 2001, Journal of neurochemistry.